Coagulopathy following major liver resection: The effect of rBPI21 and the role of decreased synthesis of regulating proteins by the liver

Shock

Volumn 15, Issue 4, 2001, Pages 261-271

  Meijer, Catharina ^a   Wiezer, Marinus J ^a   Hack, C Erik ^a,b   Boelens, Petra G ^a   Wedel, Nancy I ^c   Meijer, Sybren ^a   Nijveldt, Robert J ^a   Statius Muller, Markwin G ^a   Wiggers, Theo ^d   Zoetmulder, Frans A N ^e   Borel Rinkes, Inne H M ^f   Cuesta, Miguel A ^a   Gouma, Dirk J ^g   Van De Velde, Cornelis J H ^h   Tilanus, Hugo W ^d   Scotté, Michel ⁱ   Thijs, Lambertus G ^a   Van Leeuwen, Paul A M ^a,j  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c XOMA Corporation   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITÉ DE ROUEN   (France)

^j VU UNIVERSITY AMSTERDAM   (Netherlands)

more..

Author keywords

Coagulation and fibrinolytic pathway; Disseminated intravascular coagulation; Endotoxin; Hepatic failure; Hepatic synthesis; Partial hepatectomy

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANTIPLASMIN; ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; BILIRUBIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; COMPLEMENT COMPONENT C1S INHIBITOR; ENDOTOXIN; ENDOTOXIN BINDING PROTEINS; FIBRINOGEN; IMMUNOGLOBULIN G; INTERLEUKIN 6; MEMBRANE PROTEIN; PEPTIDE HYDROLASE; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ABDOMEN; ADULT; AGED; ARTICLE; BACTERIAL TRANSLOCATION; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; ENDOTOXEMIA; FEMALE; FIBRINOLYSIS; GASTROINTESTINAL TUMOR; HUMAN; KUPFFER CELL; LIVER; LIVER DISEASE; LIVER FAILURE; LIVER RESECTION; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

ABDOMEN; ADULT; AGED; ALPHA-MACROGLOBULINS; ANTIPLASMIN; ANTITHROMBIN III; BACTERIAL TRANSLOCATION; BILIRUBIN; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; COMORBIDITY; COMPLEMENT C1 INACTIVATOR PROTEINS; DISSEMINATED INTRAVASCULAR COAGULATION; DOUBLE-BLIND METHOD; ENDOTOXEMIA; ENDOTOXINS; FEMALE; FIBRINOGEN; FIBRINOLYSIS; GASTROINTESTINAL NEOPLASMS; HEPATECTOMY; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; KUPFFER CELLS; LIVER; LIVER DISEASES; LIVER FAILURE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMINOGEN; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; SEPSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0035319509     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115040-00003     Document Type: Article

References (37)

1. Stone MD, Benotti PN: Preoperative and postoperative care. Surg Clin North Am 69:383-392, 1989.
2. Tsuzuki T, Toyama K, Nakayasu K, Iida S, Ueda M, Toizumi A: Disseminated intravascular coagulation after hepatic resection. Surgery 107:172-176, 1990.
3. Norton L, Moore G, Eiseman B: Liver failure in the postoperative patient: the role of sepsis and immunologic deficiency. Surgery 78:6-13, 1975.
4. Bradfield JWB: Control of spillover. The importance of Kupffer-cell function in clinical medicine. Lancet 2:883-886, 1974.
5. Van Deventer SJH, Büller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A: Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 76:2520-2526, 1990.
6. Van der Poll T, Büller HR, Ten Cate H, Wortel CH, Bauer KA, Van Deventer SJH, Hack CE, Sauerwein HP, Rosenberg RD, Ten Cate JW: Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 322:1622-1627, 1990.
7. Van der Poll T, Levi M, Büller HR, Van Deventer SJH, De Boer JP, Hack CE, Ten Cate JW: Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 174:729-732, 1991.
8. Tygstrup N, Jensen SA, Krog B, Pietrangelo A, Shafritz DA: Expression of messenger RNA for liver functions following 70% and 90% hepatectomy. J Hepatol 25:72-78, 1996.
9. Izumi S, Hughes RD, Langley PG, Pernambuco JRB, Williams R: Extent of the acute phase response in fulminant hepatic failure. Gut 35:982-986, 1994.
10. Milland J, Tsykin A, Thomas T, Aldred AR, Cole T, Schreiber G: Gene expression in regenerating and acute-phase rat liver. Am J Physiol 259:G340-G347, 1990.
11. Kimura F, Miyazaki M, Suwa T, Kakizaki S, Itoh H, Kaiho T, Nakajima N: Increased serum interleukin-6 level and reduction of hepatic acute phase response after major hepatectomy. Eur Surg Res 28:96-103, 1996.
12. Von Der Möhlen MAM, Van Deventer SJH, Levi M, Van den Ende B, Wedel NI, Nelson BJ, Friedmann N, Ten Cate JW: Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23). Blood 85:3437-3443, 1995.
13. Boermeester MA, Straatsburg IH, Houdijk APJ, Meijer C, Frederiks WM, Wesdorp RIC, van Noorden CJF, van Leeuwen PAM: Endotoxin and interleukin-1 related hepatic inflammatory response promotes liver failure after partial hepatectomy. Hepatology 22:1499-1506, 1995.
14. Boermeester MA, Houdijk APJ, Meijer S, Cuesta MA, Appelmelk BJ, Wesdorp RIC, Hack CE, van Leeuwen PAM: Liver failure induces a systemic inflammatory response: prevention by recombinant N-terminal bactericidal/ permeability-increasing protein. Am J Pathol 147:1428-1440, 1995.
15. Helle M, Boeije L, De Groot ER, De Vos A, Aarden LA: Sensitive ELISA for interleukin-6: detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 38:47-56, 1991.
16. Brakenhoff JPJ, De Groot E, Evers RF, Pannekoek H, Aarden LA: Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol 39:4116-4121, 1987.
17. Jansen PM, Boermeester MA, Fischer E, De Jong IW, Van der Poll T, Moldawer LL, Hack CE, Lowry SF: Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation and the release of secretory type phospholipase A2 in sepsis: studies in non-human primates following interleukin-1α administration and during lethal bacteremia. Blood 86:1027-1034, 1995.
18. Levi M, De Boer JP, Roem D, Ten Cate JW, Hack CE: Plasminogen activation in vivo upon intravenous infusion of DDAVP: quantitative assessment of plasmin-α2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay. Thromb Haemost 67:111-116, 1992.
19. Van Zonneveld AJ, Veerman H, Brakenhoff JPJ, Aarden LA, Cajot JF, Pannekoek H: Mapping of epitopes on human tissue-type plasminogen activator with recombinant deletion mutant proteins. Thromb Haemost 57:82-86, 1987.
20. De Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voorn GP, Lambers JWJ, Van Mou-rik JA, Hack CE: PAI-1 synthesis in the human hepatoma cell line Hep G2 is increased by cytokines: evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 65:181-185, 1991.
21. Meijer C, Hack CE, Wedel NI, Thijs LG, Wiezer MJ, Wünsche R, Wiggers T, Zoetmulder FAN, Borel Rinkes IHM, Gouma DJ, Cuesta MA, Nelson BJ, Havrilla N, Meijer S, van Leeuwen PAM: Phase II clinical trial with recombinant human bactericidal/permeability: increasing protein (rBPI21) in the prevention of the inflammatory response after liver resection: results of the low dose phase. In Faist E (ed): The Immune Consequences of Trauma, Shock and Sepsis. Bologna (Italy): Monduzzi Editore, 1997, pp 769-773.
22. Wiezer MJ, Langendoen SI, Meijer C, Bauer RJ, White ML, Carroll SF, Meijer S, Thijs LG, van Leeuwen PAM: Pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability: increasing protein (rBPI21) after liver surgery in rats and humans. Shock 10:161-166, 1998.
23. Wiezer MJ, Meijer C, Teiwes P, Gouma DJ, Borel Rinkes IHM, Thijs LG, Tilanus HW, van de Velde CJH, Wiggers T, Zoetmulder FAN, Dentener MA, Meijer S, van Leeuwen PAM: Peri-operative treatment with rBPI21 in the prevention of complications after major liver resection: a randomized, double-blind, placebo-controlled, multicenter trial. (Submitted for publication)
24. Erickson LA, Ginsberg MH, Loskutoff DJ: Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Investig 74:1465-1472, 1984.
25. Wiezer MJ, Meijer C, Sietses C, Prins HA, Cuesta MA, Beelen RHJ, Meijer S, van Leeuwen PAM: Bacterial/permeability-increasing protein (rBPI21) preserves leukocyte functions after major liver resection. Ann Surg 232:208-215, 2000.
26. Wortel CH, Van Deventer SJH, Aarden LA, Lygidakis NJ, BUller HR, Hoek FJ, Horikx J, Ten Cate JW: Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery 114:564-570, 1993.
27. Hack CE, De Groot ER, Felt-Bersma RJF, Nuijens JH, Van Schijndel RJMS, Eerenberg-Belmer AJM, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710, 1989.
28. Baumann H, Gauldie J: The acute phase response. Immunol Today 15:74-80, 1994.
29. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 265:621-636, 1990.
30. Didolkar MS, Fitzpatrick JL, Elias EG, Whitley N, Keramati B, Suter CM, Brown S: Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 169:17-26, 1989.
31. Lee NW, Wong J, Ong GB: The surgical management of primary carcinoma of the liver. World J Surg 6:66-75, 1982.
32. Narita M, Rudolph AE, Miletich JP, Schwartz AL: The low-density lipoprotein receptor-related protein (LRP) mediates clearance of coagulation factor Xa in vivo. Blood 91:555-560, 1998.
33. Sanchez MC, Chiabrando GA, Guglielmone HA, Bonacci GR, Rabinovich GA, Vides MA: Interaction of human tissue plasminogen activator (t-PA) with pregnancy zone protein: a comparative study with t-PA-α2-macroglobulin interaction. J Biochem 124:274-279, 1998.
34. Mitchell L, Piovella F, Ofosu F, Andrew M: Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombtn III-deficient children. Blood 78:2299-2304, 1991.
35. Ozyilkan O, Baltali E, Ozdemir O, Tekuzman G, Kirazli S, Firat D: Haemostatic changes: plasma levels of α2-antiplasmin complex and thrombinantithrombin III complex in female breast cancer. Tumori 84:364-367, 1998.
36. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S: Evaluating pre-thrombotic state in lung cancer using molecular markers. Chest 103: 196-200, 1993.
37. Carey MJ, Rodgers GM: Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol 59:65-73, 1998.